HealthStream Lowers FY2024 Sales Guidance from $292.00M-296.00M to $290.00M-292.00M (Est. 292.373M)
Portfolio Pulse from Benzinga Newsdesk
HealthStream has revised its FY2024 sales guidance downwards from $292.00M-296.00M to $290.00M-292.00M, slightly below the estimated $292.373M.
October 21, 2024 | 8:33 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
HealthStream has lowered its FY2024 sales guidance to $290M-$292M, which is slightly below the market estimate of $292.373M. This revision may indicate potential challenges in meeting previous sales expectations.
The downward revision in sales guidance suggests that HealthStream may face challenges in achieving its previous sales targets. This could lead to negative sentiment among investors, potentially putting short-term pressure on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100